Mainstream

Mersana targets reporting initial Emi-Le expansion data in H2 2025 while achieving $15M GSK milestone

Mersana targets reporting initial Emi-Le expansion data in H2 2025 while achieving $15M GSK milestone

Post ContentmrsnRead More

You might also be interested in reading Bitmine Immersion’s Tom Lee-led SPAC Futurecrest prices ~$250M IPO.

August 13, 2025
In Mainstream